info@synchemia.com | sales@synchemia.com 
9766925136 
Alogliptin
Alogliptin | CAS NO: 850649-61-5 Blood Sugar Control: Alogliptin is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes. Combination Therapy: It can be used alone or in combination with other diabetes medications, such as metformin or sulfonylureas, to enhance blood sugar management. Cardiovascular Benefits: Some studies suggest it may have cardiovascular benefits, but it is not primarily prescribed for this purpose.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Alogliptin impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities Alogliptin is primarily used to manage type 2 diabetes. It belongs to a class of medications called DPP-4 inhibitors, which help increase insulin release and decrease glucose production in the liver, particularly after meals. we the Synchemia are ensuring the purity and quality of its impurities which is crucial for pharmaceutical API manufacturing companies for regulatory compliance. Buy Reliable and High-Purity Alogliptin Impurities, Delivered by Synchemia Research Chemicals.
Download catalogue
Pharmaceutical Reference Standards
| CAT No | SRC-A177 |
| CAS No | 2749424-28-8 |
| Mol.F. | C26H26N6O2 |
| Mol.Wt. | 454.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A178 |
| CAS No | 2749281-73-8 |
| Mol.F. | C25H25N5O3 |
| Mol.Wt. | 443.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A179 |
| CAS No | 865758-98-1 |
| Mol.F. | C17H19N5O2 |
| Mol.Wt. | 325.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A180 |
| CAS No | 1820685-30-0 |
| Mol.F. | C18H23N5O3 |
| Mol.Wt. | 357.4 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-A181 |
| CAS No | 1108731-49-2 |
| Mol.F. | C20H23N5O3 |
| Mol.Wt. | 381.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A182 |
| CAS No | 2748587-69-9 |
| Mol.F. | C18H22N4O4 |
| Mol.Wt. | 358.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A183 |
| CAS No | 655-63-0 |
| Mol.F. | C8H5Br2N |
| Mol.Wt. | 274.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A184 |
| CAS No | 1246610-72-9 |
| Mol.F. | C13H11N3O3 |
| Mol.Wt. | 257.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A185 |
| CAS No | 865759-10-0 |
| Mol.F. | C25H24N6O2 |
| Mol.Wt. | 440.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A186 |
| CAS No | 1246610-74-1 |
| Mol.F. | C23H29N5O4 |
| Mol.Wt. | 439.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A187 |
| CAS No | 865758-96-9 |
| Mol.F. | C13H10ClN3O2 |
| Mol.Wt. | 275.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A188 |
| CAS No | 1246610-74-1 |
| Mol.F. | C23H29N5O4 |
| Mol.Wt. | 439.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A189 |
| CAS No | 2565-47-1 |
| Mol.F. | C5H6N2O3 |
| Mol.Wt. | 142.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A190 |
| CAS No | 1638544-64-5 |
| Mol.F. | C18H21N5O2 : C7H6O2 |
| Mol.Wt. | 339.4 : 122.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A191 |
| CAS No | 2514763-78-9 |
| Mol.F. | C14H13N3O3 |
| Mol.Wt. | 271.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A192 |
| CAS No | NA |
| Mol.F. | C18H21N5O2 : HCl |
| Mol.Wt. | 339.4 : 36.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
